JP2005528359A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005528359A5 JP2005528359A5 JP2003577780A JP2003577780A JP2005528359A5 JP 2005528359 A5 JP2005528359 A5 JP 2005528359A5 JP 2003577780 A JP2003577780 A JP 2003577780A JP 2003577780 A JP2003577780 A JP 2003577780A JP 2005528359 A5 JP2005528359 A5 JP 2005528359A5
- Authority
- JP
- Japan
- Prior art keywords
- transdermal
- depression
- dosage
- buprenorphine
- transdermal dosage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 6
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 claims 3
- 229960001736 buprenorphine Drugs 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 2
- 208000024891 symptom Diseases 0.000 claims 2
- 239000006211 transdermal dosage form Substances 0.000 claims 2
- 238000009792 diffusion process Methods 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 229940100640 transdermal system Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36635802P | 2002-03-20 | 2002-03-20 | |
| PCT/US2003/008796 WO2003079945A1 (en) | 2002-03-20 | 2003-03-20 | Method of administering buprenorphine to treat depression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005528359A JP2005528359A (ja) | 2005-09-22 |
| JP2005528359A5 true JP2005528359A5 (enExample) | 2006-05-11 |
Family
ID=28454789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003577780A Pending JP2005528359A (ja) | 2002-03-20 | 2003-03-20 | うつ病の治療のためのブプレノルフィンの投与方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20030181475A1 (enExample) |
| EP (1) | EP1485051B1 (enExample) |
| JP (1) | JP2005528359A (enExample) |
| AT (1) | ATE394097T1 (enExample) |
| AU (1) | AU2003224742A1 (enExample) |
| CY (1) | CY1108217T1 (enExample) |
| DE (1) | DE60320770D1 (enExample) |
| DK (1) | DK1485051T3 (enExample) |
| ES (1) | ES2305457T3 (enExample) |
| PT (1) | PT1485051E (enExample) |
| SI (1) | SI1485051T1 (enExample) |
| WO (1) | WO2003079945A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968547A (en) | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
| EP1913938A1 (en) * | 2002-12-13 | 2008-04-23 | Euro-Celtique S.A. | Transdermal buprenorphine dosage regimen for analgesia |
| MXPA05006334A (es) * | 2002-12-13 | 2005-08-26 | Euro Celtique Sa | Dosis de buprenorfina transdermica para analgesia. |
| US8790689B2 (en) | 2003-04-30 | 2014-07-29 | Purdue Pharma L.P. | Tamper resistant transdermal dosage form |
| MY141815A (en) | 2003-04-30 | 2010-06-30 | Purdue Pharma Lp | Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer |
| UA81056C2 (en) | 2003-07-25 | 2007-11-26 | Euro Celtic S A | Method for treatment of dependence withdrawal in pregnant women by transdermal administration of buprenorphine |
| DE10340428B4 (de) * | 2003-09-02 | 2015-02-12 | Acino Ag | Opioides Analgetikum enthaltende transdermale Formulierung |
| FR2865650B1 (fr) * | 2004-01-30 | 2008-06-13 | Biocortech | Utilisation du 14,15 dihydro 20,21-dinoreburnamenin14-ol pour traiter et/ou prevenir les depressions majeures et les desordres du cycle veille-sommeil |
| DE102004045599A1 (de) * | 2004-09-17 | 2006-03-23 | Grünenthal GmbH | System zur sequentiellen, transdermalen Verabreichung von systemisch wirksamen Substanzen |
| DE102005007859A1 (de) * | 2005-02-21 | 2006-08-24 | Lts Lohmann Therapie-Systeme Ag | Vefahren für eine medikamentöse Kombinations-Behandlung, sowie hierfür geeignete Arzneimittel-Kombinationen |
| DE102006011340A1 (de) * | 2006-03-09 | 2007-09-20 | Grünenthal GmbH | Wirkstoffhaltige Pflaster mit verbesserter Handhabung |
| SMT201900357T1 (it) | 2009-12-04 | 2019-07-11 | Alkermes Pharma Ireland Ltd | Derivati di morfinano per trattamento di abuso di sostanze stupefacenti |
| SI2608670T1 (sl) | 2010-08-23 | 2019-04-30 | Alkermes Pharma Ireland Limited | Postopki za zdravljenje pridobivanja teže, ki je posledica uporabe antipsihotičnih zdravil |
| WO2013042054A1 (en) * | 2011-09-19 | 2013-03-28 | Carmel - Haifa University Economic Corporation Ltd. | Buprenorphine for the treatment of acute suicidality |
| US9211293B2 (en) | 2011-12-15 | 2015-12-15 | Alkermes Pharma Ireland Limited | Opioid agonist antagonist combinations |
| AU2012351806C1 (en) | 2011-12-15 | 2016-06-16 | Alkermes Pharma Ireland Limited | Compositions of buprenorphine and mu-opioid receptor antagonists |
| US10195191B2 (en) | 2011-12-15 | 2019-02-05 | Alkermes Pharma Ireland Limited | Opioid agonist antagonist combinations |
| EP2790703B1 (en) * | 2011-12-15 | 2019-06-12 | Alkermes Pharma Ireland Limited | Samidorphan (alks 33) in combination with opioid agonists |
| NZ631018A (en) | 2013-05-24 | 2017-12-22 | Alkermes Pharma Ireland Ltd | Morphan and morphinan analogues, and methods of use |
| EP3003311A2 (en) | 2013-05-24 | 2016-04-13 | Alkermes Pharma Ireland Limited | Methods for treating depressive symptoms |
| AU2014368548B2 (en) | 2013-12-20 | 2019-09-19 | H. Lundbeck A/S | Use of an opioid receptor antagonist with kappa-activity and vortioxetine for treatment of depressive disorder with melancholic features |
| WO2022101444A1 (en) | 2020-11-12 | 2022-05-19 | Alkermes Pharma Ireland Limited | Immediate release multilayer tablet |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4806341A (en) * | 1985-02-25 | 1989-02-21 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration |
| US5026556A (en) * | 1988-11-10 | 1991-06-25 | Norwich Eaton Pharmaceuticals, Inc. | Compositions for the transdermal delivery of pharmaceutical actives |
| US4956171A (en) * | 1989-07-21 | 1990-09-11 | Paco Pharmaceutical Services, Inc. | Transdermal drug delivery using a dual permeation enhancer and method of performing the same |
| US5240711A (en) * | 1989-11-29 | 1993-08-31 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system comprising as active component buprenorphine |
| DK0484543T3 (da) * | 1990-04-24 | 1996-01-22 | Teijin Ltd | Plaster |
| US5069909A (en) * | 1990-06-20 | 1991-12-03 | Cygnus Therapeutic Systems | Transdermal administration of buprenorphine |
| US5512593A (en) * | 1993-03-02 | 1996-04-30 | John S. Nagle | Composition and method of treating depression using natoxone or naltrexone in combination with a serotonin reuptake inhibitor |
| US5613958A (en) * | 1993-05-12 | 1997-03-25 | Pp Holdings Inc. | Transdermal delivery systems for the modulated administration of drugs |
| US6165499A (en) * | 1996-03-25 | 2000-12-26 | Lts Lohmann Therapie-Systeme Gmbh | Transdermal therapeutic system with small application-area thickness and great flexibility, and production process |
| US6787149B1 (en) * | 1996-12-12 | 2004-09-07 | El Khoury And Stein Ltd. | Topical application of opioid analgesic drugs such as morphine |
| US5968547A (en) * | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
| US5900420A (en) * | 1997-06-19 | 1999-05-04 | Cole; William L. | Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine |
| DE19738855C2 (de) * | 1997-09-05 | 2001-01-04 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit haftklebender Reservoirschicht und unidirektional elastischer Rückschicht |
| DE19746191C2 (de) * | 1997-10-18 | 2000-05-18 | Lohmann Therapie Syst Lts | Verfahren zur Anwendung eines Wirkstoff enthaltenden Pflasters zur Bekämpfung oder Linderung einer Sucht |
| US6242456B1 (en) * | 1998-03-09 | 2001-06-05 | Trustees Of Tufts College | Treatment of stereotypic, self-injurious and compulsive behaviors in man and animals using antagonists of NMDA receptors |
| DE19840758A1 (de) * | 1998-09-07 | 2000-03-09 | Liedtke Pharmed Gmbh | Systemische Therapie von Schmerz- und depressiver Befindlichkeit |
-
2003
- 2003-03-20 US US10/394,425 patent/US20030181475A1/en not_active Abandoned
- 2003-03-20 EP EP03721427A patent/EP1485051B1/en not_active Expired - Lifetime
- 2003-03-20 AT AT03721427T patent/ATE394097T1/de active
- 2003-03-20 SI SI200331272T patent/SI1485051T1/sl unknown
- 2003-03-20 WO PCT/US2003/008796 patent/WO2003079945A1/en not_active Ceased
- 2003-03-20 AU AU2003224742A patent/AU2003224742A1/en not_active Abandoned
- 2003-03-20 DK DK03721427T patent/DK1485051T3/da active
- 2003-03-20 DE DE60320770T patent/DE60320770D1/de not_active Expired - Lifetime
- 2003-03-20 ES ES03721427T patent/ES2305457T3/es not_active Expired - Lifetime
- 2003-03-20 PT PT03721427T patent/PT1485051E/pt unknown
- 2003-03-20 JP JP2003577780A patent/JP2005528359A/ja active Pending
-
2008
- 2008-07-28 CY CY20081100780T patent/CY1108217T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005528359A5 (enExample) | ||
| CY1107262T1 (el) | Θεραπεια της εξαρτησης στερησης | |
| JP2011252020A5 (enExample) | ||
| WO2001082914A3 (en) | Topical anesthetic/opioid formulations and uses thereof | |
| NO20001175D0 (no) | Smertestillende blandinger omfattende anti-epileptiske forbindelser og fremgangsmÕter for anvendelse derav | |
| JP2009544619A5 (enExample) | ||
| UA88464C2 (ru) | Способ дермального введения метадоновой композиции с обеспечением системного действия | |
| DE60034667D1 (de) | Pharmazeutische zusammensetzung aus komplexen kohlenhydraten deren anwendung | |
| JP2007500134A5 (enExample) | ||
| WO2004080413A3 (en) | Uses and formulations for transdermal or transmucosal application of active agents | |
| CY1108217T1 (el) | Μεθοδος χορηγησης βουπρενορφινης για τη θεραπεια της καταθλιψης | |
| WO2007012019A3 (en) | Medicaments containing famotidine and ibuprofen and administration of same | |
| JP2006513184A5 (enExample) | ||
| DK1572167T3 (da) | Transdermal buprenophindoseringsbehandlingsplan for analgesi | |
| AU5706301A (en) | Topical formulations for the transdermal delivery of niacin and methods of treating hyperlipidemia | |
| BRPI0514600A (pt) | métodos para a fabricação de um composto, para a purificação de um composto, para o tratamento de um indivìduo tendo uma condição neoplástica, tendo carcinoma de célula escamosa, e tendo carcinoma de célula basal, para a redução ou prevenção da ocorrência de uma condição neoplástica em um indivìduo, e para a redução de triglicerìdeos no soro em um indivìduo, composto, e, composição farmacêutica | |
| RU2002103808A (ru) | Способ лечения болевого синдрома у онкологических больных | |
| WO2003059284A3 (en) | Composition and method for inhibiting hypersensitivity | |
| WO2006117404A3 (de) | Topische verwendung von radikalfangenden substanzen zur antipyretischen behandlung | |
| JPWO2020079692A5 (enExample) | ||
| WO2013096811A3 (en) | Transmucosal drug delivery devices for use in chronic pain relief | |
| RU2000105967A (ru) | Способ лечения абстинентного синдрома у больных зависимостью от трамала | |
| RU2000111645A (ru) | Способ лечения геморрагической лихорадки с почечным синдромом | |
| RU99107874A (ru) | Способ лечения абстинентного синдрома у больных героиновой наркоманией | |
| RU99105224A (ru) | Способ местного лечения свищевого дерматита |